Stockscreener 앱 받기
2.71
11.73%
-0.36
시간 외 거래:
2.66
-0.05
-1.85%
전일 마감가:
$3.07
열려 있는:
$2.95
하루 거래량:
10.16M
Relative Volume:
0.90
시가총액:
$93.34M
수익:
-
순이익/손실:
$-20.34M
주가수익비율:
-3.8881
EPS:
-0.697
순현금흐름:
$-15.59M
1주 성능:
+27.83%
1개월 성능:
+59.41%
6개월 성능:
+71.52%
1년 성능:
+4.43%
1일 변동 폭
$2.50
$3.24
1주일 범위
$2.03
$4.00
52주 변동 폭
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
명칭
Heartbeam Inc
전화
408-899-4443
주소
2118 WALSH AVE., SUITE 210, SANTA CLARA
BEAT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
2.71 | 105.74M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
218.10 | 35.42B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
62.21 | 11.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
43.49 | 8.23B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.50 | 8.14B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
36.64 | 6.42B | 11.99B | 24.18M | 234.31M | 0.2956 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-11 | 업그레이드 | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | 개시 | H.C. Wainwright | Buy |
| 2025-10-31 | 개시 | Roth Capital | Buy |
| 2020-09-11 | 개시 | Needham | Buy |
| 2020-09-02 | 개시 | Robert W. Baird | Neutral |
| 2020-01-08 | 개시 | SunTrust | Buy |
| 2019-08-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | 재확인 | Dougherty & Company | Buy |
| 2018-07-26 | 재확인 | Lake Street | Buy |
| 2018-04-26 | 재확인 | The Benchmark Company | Buy |
| 2018-02-23 | 재확인 | Dougherty & Company | Buy |
| 2017-11-08 | 재확인 | Dougherty & Company | Buy |
| 2017-10-26 | 개시 | Raymond James | Outperform |
| 2017-10-24 | 개시 | SunTrust | Buy |
| 2017-08-09 | 재확인 | Dougherty & Company | Buy |
| 2017-07-19 | 재확인 | The Benchmark Company | Buy |
| 2017-04-11 | 재확인 | Dougherty & Company | Buy |
| 2016-12-02 | 개시 | Dougherty & Company | Buy |
| 2016-09-13 | 개시 | Sidoti | Buy |
| 2016-08-03 | 재확인 | The Benchmark Company | Buy |
| 2015-07-28 | 재확인 | Dougherty & Company | Buy |
| 2013-10-24 | 개시 | The Benchmark Company | Buy |
| 2013-08-21 | 개시 | Dougherty & Company | Buy |
모두보기
Heartbeam Inc 주식(BEAT)의 최신 뉴스
HeartBeam (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - TipRanks
Will HeartBeam Inc. Equity Warrant stock outperform tech sector in 2025Market Trend Summary & Precise Trade Entry Recommendations - Улправда
Will HeartBeam Inc. stock deliver shareholder value2025 Market WrapUp & Reliable Entry Point Trade Alerts - Улправда
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reportsJuly 2025 Technicals & Consistent Profit Trade Alerts - Улправда
Analyst Downgrade: How institutional buying supports HeartBeam Inc. Equity Warrant stock2025 Valuation Update & Detailed Earnings Play Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Retail Activity & Daily Chart Pattern Signal Reports - Улправда
HeartBeam Shares Tumble: Road to Recovery? - StocksToTrade
AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Ranks Second Worldwide in 12-Lead ECG Innovation - FinancialContent
HeartBeam (BEAT) Stock News Today: FDA Clearance Ignites Rally, Analysts Lift Targets, and What Investors Are Watching Next (Dec. 17, 2025) - ts2.tech
HeartBeam Stock Surges 388%, With A 9-Day Winning Spree - Trefis
HeartBeam Earns FDA Clearance for 12-Lead Synthesis Software - Diagnostic and Interventional Cardiology
HeartBeam’s Stock Soars After FDA Clearance for Innovative ECG Technology - StocksToTrade
HeartBeam Stock Surges 273%, With A 8-Day Winning Spree - Trefis
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
HeartBeam Stock 7-Day Winning Spree: Stock Climbs 227% - Trefis
Heartbeam Inc. (BEAT) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
HeartBeam Shares Skyrocket: FDA Boost - timothysykes.com
HeartBeam Soars with FDA Approval for Breakthrough ECG Technology - timothysykes.com
HeartBeam Stock Soars: Should You Buy? - timothysykes.com
symbol__ Stock Quote Price and Forecast - CNN
Heartbeam stock is a buy, this analyst says - Cantech Letter
HeartBeam Stock Surges 201%, With A 6-Day Winning Spree - Trefis
Benchmark Upgrades HeartBeam (BEAT) - Nasdaq
BEAT Secures FDA Nod for First Cable-Free At-Home 12-Lead ECG System - sharewise.com
HeartBeam updates regulatory strategy for 12-lead ECG Synthesis Software - MSN
HeartBeam Stock Surges: Analyzing the Uptrend - StocksToTrade
Why Is Micro Cap HeartBeam Stock Surging On Wednesday? - Sahm
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
HeartBeam swells on turning FDA rejection into ECG clearance - Fierce Biotech
3 Penny Stocks to Watch Now, 12/11/25 - TipRanks
Why did BEAT stock rocket 72% in pre-market today? - MSN
HeartBeam receives US FDA clearance for at-home arrhythmia assessment with cable-free 12-lead ECG - Cardiac Rhythm News
HeartBeam (BEAT) Receives Upgrade from Benchmark Analyst | BEAT Stock News - GuruFocus
HeartBeam go-to-market strategy remains on track, says Benchmark - TipRanks
HeartBeam stock soars as H.C. Wainwright doubles price target on FDA clearance - Investing.com India
HeartBeam sinks after ‘Not Substantially Equivalent’ letter from FDA - MSN
HeartBeam (BEAT) Stock Soars After FDA Clearance: Latest News, Forecasts and Analyst Views - ts2.tech
Most Active U.S. Stocks Today: HeartBeam, Nvidia, Tesla, Netflix and Nextdoor Lead Volatile Trade (Dec. 11, 2025) - ts2.tech
5-Day Rally Sends HeartBeam Stock Up 120% - Trefis
HeartBeam Receives FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz
HeartBeam announces FDA clearance for 12-lead ECG synthesis software - MSN
Oracle, Synopsys, Heartbeam, Planet Labs And Adobe: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
HC Wainwright & Co. Maintains HeartBeam (BEAT) Buy Recommendation - Nasdaq
Heartbeam wins appeal, gains FDA clearance - BioWorld MedTech
HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - NewMediaWire
FDA Greenlight Sends HeartBeam, Photronics, And Designer Brands Shares Climbing - Finimize
HeartBeam (NASDAQ: BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal - Digital Journal
HeartBeam’s Leap: Should Investors Be Wary? - StocksToTrade
FDA Clears HeartBeam Cable-free 12-lead ECG - respiratory-therapy.com
HeartBeam Secures FDA Clearance for 12-Lead ECG Synthesis Software Following Appeal - citybuzz
HeartBeam (BEAT) Stock: Surges 50% After FDA Grants Clearance For its 12-lead ECG Device - parameter.io
Heartbeam Inc (BEAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.00%
자본화:
|
볼륨(24시간):